Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/30/17 | 8-K | Current report filing |
|
25 | |
| 02/28/17 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
59 | |
| 02/28/17 | 8-K | Current report filing |
|
35 | |
| 02/13/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/13/17 | 8-K | Current report filing |
|
7 | |
| 01/31/17 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
59 | |
| 01/31/17 | 8-K | Current report filing |
|
49 | |
| 01/30/17 | 8-K | Current report filing |
|
7 | |
| 01/13/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
33 |
| 01/05/17 | 8-K | Current report filing |
|
7 |
